Long-term follow-up study of cats vaccinated with a temperature-sensitive feline infectious peritonitis vaccine.
The long-term safety of a temperature-sensitive feline infectious peritonitis (FIP) vaccine was evaluated. Five hundred eighty-two healthy cats of various age groups were vaccinated with 2 doses of the vaccine. Seventy-eight percent, or 453 cats, were available for follow-up. The mean follow-up period was 541 days. At the end of the follow-up period, 427 cats (94%) were alive. FIP was not diagnosed in any cat during the follow-up period, but 1 cat died of FIP after completion of the follow-up period. Fifty cats (11%) presented with a problem during the follow-up period, but there were typical of those seen in a feline practice. The temperature-sensitive FIP vaccine appears to be safe for use in the general cat population. It does not appear to sensitize cats to develop FIP, nor do there appear to be any other systemic problems associated with use of the vaccine.
Reeves
N C
NC
SmithKline Beecham Animal Health, West Chester, PA 19380.
Pollock
R V
RV
Thurber
E T
ET
D000281:Administration, Intranasal; D000818:Animals; D002415:Cats; D002423:Cause of Death; D016765:Coronavirus, Feline / Q000276:immunology*; D016766:Feline Infectious Peritonitis / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D008297:Male; D012189:Retrospective Studies; D014611:Vaccination / Q000662:veterinary; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects*
D014765:Viral Vaccines